DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

15.41 0.90 (6.20%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLDX $15.41 6.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.73
Previous Close $14.51
Daily Range $14.71 - $15.63
52-Week Range $10.76 - $33.33
Market Cap $1.4B
P/E Ratio -12.09
Dividend (Yield) $0.00 (0.0%)
Volume 1,823,456
Average Daily Volume 1,889,466
Current FY EPS -$1.32





Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website:

News & Commentary Rss Feed

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

Celldex Therapeutics Breaks Resistance

Strong On High Volume: Celldex Therapeutics (CLDX)

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

Top Analyst Upgrades and Downgrades: Altria, Celldex, Linkedin, Nike, Seadrill, Verizon and More

Why You Shouldn't Bet Against Celldex Therapeutics (CLDX) Stock - Tale of the Tape

Celldex Therapeutics' CEO Presents at Morgan Stanley Healthcare Conference (Transcript)

Steve Brozak: Big-Picture Biotech Stocks Rule The Future

Celldex Therapeutics (CLDX) Worth Watching: Stock Rises 9.1% - Tale of the Tape

See More CLDX News...

CLDX's Top Competitors

CLDX $15.41 (6.20%)
Current stock: CLDX
AMGN $147.25 (2.51%)
Current stock: AMGN
GILD $107.18 (1.03%)
Current stock: GILD
BIIB $316.06 (2.26%)
Current stock: BIIB